Bank of America’s HTG Molecular Diagnostics, Inc. Common Stock HTGM Stock Holding History

Bank of America’s Portfolio HTGM Stock Details HTGM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-278	Closed	-$19K	–	8904
2021 Q3	$19K	Buy	+278	New	+$19.9K	﹤0.01%	7411
2021 Q2	–	Sell	-2	Closed	–	–	8291
2021 Q1	$0	Buy	+2	New	+$152	﹤0.01%	7939
2019 Q4	–	Sell	-190	Closed	-$23K	–	7547
2019 Q3	$23K	Buy	190 +185	+3,700%	+$37.3K	﹤0.01%	6559
2019 Q2	$2K	Buy	+5	New	+$2.08K	﹤0.01%	6979
2018 Q4	–	Sell	-5	Closed	-$5K	–	7495
2018 Q3	$5K	Buy	+5	New	+$3.3K	﹤0.01%	6847
2018 Q2	–	Sell	-9	Closed	-$6K	–	7410
2018 Q1	$6K	Buy	+9	New	+$6.76K	﹤0.01%	6744
2017 Q1	–	Hold	0	–	–	–	7335
2016 Q4	–	Hold	0	–	–	–	7432
2016 Q3	–	Hold	0	–	–	–	7445
2016 Q2	–	Hold	0	–	–	–	7483

Other funds holding HTGM

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

CPA

Cowen Prime Advisors New York $290M AUM 57.8% 1-Year Est. Return

Samjo Capital New York $254M AUM 36.81% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America's HTGM Position: Q4 2021 in Review

Bank of America sold out of HTG Molecular Diagnostics, Inc. Common Stock (HTGM) in Q4 2021, closing a stake of 278 shares — an estimated $19K sold.

Bank of America first reported a position in HTGM in Q1 2018 and held it in 6 quarters. The position peaked at $23K in Q3 2019. 21 funds tracked by Wall St. Rank hold HTGM as of Q4 2021.

Bank of America reported no remaining HTG Molecular Diagnostics, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
Bank of America sold 278 HTG Molecular Diagnostics, Inc. Common Stock shares in Q4 2021, an estimated $19K.
Bank of America first reported a position in HTG Molecular Diagnostics, Inc. Common Stock in Q1 2018 and held it in 6 quarters.
Bank of America's HTG Molecular Diagnostics, Inc. Common Stock position peaked at $23K in Q3 2019.
21 funds tracked by Wall St. Rank held HTG Molecular Diagnostics, Inc. Common Stock as of Q4 2021.

Based on Bank of America's 13F filing for Q4 2021, filed 8 Feb 2022.